Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac administration route comparison for analgesia in adult squint surgery
IRCT20210106049952N2Phase 2Completed
- Sponsor
- Research Institute of Ophthalmology
- Start
- Nov 2021
- Modality
- Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of ketorolac, lidocaine and hyaluronidase in strabismus (3 arms), sponsored by Research Institute of Ophthalmology. Primary endpoints: Onset of sensory block, Onset of motor block and 3 more. Started Nov 2021; status: completed.
02
Drugs
ketorolaclidocainehyaluronidase
03
Conditions
strabismus
Beyond the preview
Go deeper on IRCT20210106049952N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210106049952N2.